¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fracture fragment"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® fracture ÇÑ±Û °ñÀý
¼³¸í   
  1. °­ÇÑ ¿Ü·ÂÀÌ ÀÛ¿ëÇÏ¿© »À°¡ ºÎºÐÀûÀ¸·Î ¶Ç´Â ¿ÏÀüÈ÷ À̴ܵȠ»óÅÂ. Å« ¿Ü·ÂÀÌ ÀϽÿ¡ °¡ÇØÁú ¶§´Â ¿Ü»ó¼º °ñÀý. ¸¸¼ºÀûÀΠ°¡¾Ð¿¡ ÀÇÇÒ ¶§´Â Áö¼Ó°ñÀý ¶Ç´Â ÇǷΰñÀý, º´ÀûÀ¸·Î Á¶Á÷ÀÌ Ä§ÇØµÇ¾î »ý±â´Â °ÍÀº º´Àû °ñÀýÀ̶ó ÇÑ´Ù. °ñÀýÀº ±äÅë»À Áï ³Ò´Ù¸®»À³ª ÀÚ»À µî ¿Ü¿¡ ³³ÀÛ»À, Áï ¸Ó¸®»À µî¿¡µµ ÀϾ´Ù. °ñÀýÀº ±× Çü»óÀ¸·Î º» ¼±»ó°ñÀý-ÇÔ¸ô°ñÀý µî°ú °°Àº °³¹æÃ¢À» ¼ö¹ÝÇϴ °ÍÀ» °³¹æ°ñÀý ¶Ç´Â º¹Àâ°ñÀýÀ̶ó ÇÑ´Ù. ±äÅë»ÀÀÇ °ñÀýÀº ±× °ñÀý´ÜÀÇ °ü°è¿¡¼­ ±¼Àý°ñÀý-Àü´Ü°ñÀý-ºÐ¼â°ñÀý µîÀ¸·Î ±¸ºÐµÈ´Ù. °ñÀýÀÇ Ä¡·á´Â °ñÀý´ÜÀ» Á¤À§Ä¡¿¡ Á¢Âø½ÃÄÑ ¾çÂÊÀÇ °ñÀ¯ÇÕÀÌ µÉ ¶§±îÁö ºÎµ¿À¸·Î °íÁ¤½ÃŲ´Ù. ±äÅë»À·Î¼­ °­ÇÑ ±ÙÀ°ÀÌ ºÎÂøµÇ¾î Àִ ºÎºÐ¿¡ °ñÀýÀÌ »ý±â¸é À̿Ͱ°Àº Á¢Âø-°íÁ¤ÀÌ ½±Áö ¾Ê±â ¶§¹®¿¡ ¿©·¯ °¡Áö ¹æ¹ýÀÌ °í¾È-¿¬±¸µÇ¾î ¿Ô´Ù. 2. ±¸°­¿Ü°úÀûÀ¸·Î´Â Ä¡¾Æ ¶Ç´Â °ñÁ¶Á÷ÀÇ ÆÄÀýÀ̳ª °ñÀýÀ» ¶æÇϸç, º¸Ã¶¿µ¿ª¿¡¼­´Â ÀÇÄ¡³ª Å¬·¡½ºÇÁÀÇ ÆÄ¼Õ µîÀ» ÅëĪÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fracture fragment
    °ñÀýÁ¶°¢, °ñÀýÀýÆí
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • acentric fragment
    ¹«Áß½ÉÀýÁ¶°¢, ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • bone fragment
    »ÄÁ¶°¢, °ñÆí
  • Fc fragment
    FcºÐÀý
  • fallen fragment sign
    ³«ÇÏÆÄÆí¡ÈÄ
  • fragment
    Á¶°¢, Æí
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
  • apophyseal fracture
    °ßÀΰñ´Ü°ñÀý, »Àµ¹±â°ñÀý
  • avulsion fracture
    Âõ±è°ñÀý, °ß¿­°ñÀý
  • alveolar fracture
    ÀÌÆ²°ñÀý, Ä¡Á¶°ñÀý
  • bending fracture
    ±ÁÈû°ñÀý, ±¼Àý°ñÀý
  • Bennett¡¯s fracture
    º£³Ý°ñÀý
  • blow-in fracture
    ¾È¿Í³»ÆÄ¿­°ñÀý, ´«È®¾ÈÂÊÆÄ¿­°ñÀý
  • blow-out fracture
    ¾È¿Í¿ÜÆÄ¿­°ñÀý, ´«È®¹Ù±ùÆÄ¿­°ñÀý
  • bursting fracture
    ÆÄ¿­°ñÀý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragment
    Á¶°¢
  • bone fragment
    »ÄÁ¶°¢
  • fracture
    °ñÀý
  • avulsion fracture
    Âõ±è°ñÀý, °ß¿­°ñÀý
  • bursting fracture
    ÆÄ¿­°ñÀý
  • linear fracture
    ¼±°ñÀý
  • osteochondral fracture
    »À¿¬°ñ°ñÀý, °ñ¿¬°ñ°ñÀý
  • pathologic fracture
    º´Àû°ñÀý
  • pressure fracture
    ¾Ð¹Ú°ñÀý
  • spontaneous fracture
    ÀÚ¿¬°ñÀý
  • stress fracture
    ±äÀå°ñÀý, ÇǷΰñÀý
  • transverse fracture
    °¡·Î°ñÀý, Ⱦ°ñÀý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fracture fragment
    °ñÀýÁ¶°¢, °ñÀýÀýÆí
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acentric fragment
    ¹«Áß½ÉÀýÁ¶°¢, ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • bone fragment
    »ÀÁ¶°¢, °ñÆí
  • fragment
    Á¶°¢
  • fallen fragment sign
    ³«ÇÏÆÄÆí¡ÈÄ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • alveolar fracture
    ÀÌÆ²°ñÀý, Ä¡Á¶°ñÀý
  • apophyseal fracture
    °ßÀΰñ´Ü°ñÀý, »Àµ¹±â°ñÀý
  • avulsion fracture
    Âõ±è°ñÀý, °ß¿­°ñÀý
  • bending fracture
    ±ÁÈû°ñÀý, ±¼Àý°ñÀý
  • blow-in fracture
    ¾ÈÂÊÆÄ¿­°ñÀý
  • blow-out fracture
    ¹Ù±ùÆÄ¿­°ñÀý
  • bursting fracture
    ÆÄ¿­°ñÀý
  • butterfly fracture
    ³ªºñ¸ð¾ç°ñÀý, Á¢Çü°ñÀý
  • buttonhole fracture
    °üÅë°ñÀý, ±¸¸Û°ñÀý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fracture fragment
    °ñÀý Æí(Íéï¹ø¸).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • F(ab) fragment
    F(ab)Á¶°¢
  • Fab fragment
    Fab ºÐÀý.
  • Fab fragment
    Fab Á¶°¢.
  • Fab fragment
    Fab ºÐÀý
  • acentric fragment
    ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • fragment
    ¼¼Æí, ÆÄÆí(÷òø¸), ´ÜÆí(Ó¨ø¸), ºÐÀý, ÆíÀý, °ñÆí(Íéø¸).
  • fragment
    ÀýÆí, ºÐÀý, Á¶°¢
  • Fracture
    °ñÀý(Íéï¹)
  • Le Fort fracture
    »ó¾Ç°ñÀý, ¸£Æ÷Æ®°ñÀý
  • apophyseal fracture
    °ßÀÎ °ñ´Ü °ñÀý(̲ìÚÍéÓ®Íéï¹), °ñ´Ü °ñÀý(ÍéÓ®Íéï¹).
  • articular fracture =joint f.
    °üÀý °ñÀý, °üÀý³» °ñÀý(¡­Ò®Íéï¹).
  • fracture
    °ñÀý(Íéï¹), ÆÄ¼Õ.
  • fracture
    Àý´Ü
  • fracture
    °ñÀý, ÆÄ¼Õ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fracture fragment
    °ñÀý Æí(Íéï¹ø¸).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acentric fragment
    ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • bone fragment
    °ñÆí(Íéø¸), °ñ Á¶°¢.
  • detached fragment
    À¯¸®(°ñ)Æí(ë´ìÆÍéø¸).
  • fallen fragment sign
    ³«ÇÏ ÆÄÆí ¡ÈÄ
  • fragment
    ÀýÆí, ºÐÀý, Á¶°¢
  • fragment
    ¼¼Æí, ÆÄÆí(÷òø¸), ´ÜÆí(Ó¨ø¸), ºÐÀý, ÆíÀý, °ñÆí(Íéø¸).
  • restriction fragment length polymorphism
    Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡­Òýû¡à÷)
  • restriction fragment length polymorphism,in cystic fibrosis
    ³¶¼º¼¶À¯Áõ(ÀÇ)¡­(Ò¥àõàéë«ñø¡­)
  • restriction fragment length polymorphism analysis
    Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
  • restriction fragment length polymorphism=RFLP
    Á¦ÇÑÀýÆí±æÀ̴پ缺
  • urinary gonadotropin fragment/peptide
    ¿äÁß¼º¼±ÀÚ±ØÈ£¸£¸óºÐÀý/ÆéƼµå
  • apophyseal fracture
    °ßÀÎ °ñ´Ü °ñÀý(̲ìÚÍéÓ®Íéï¹), °ñ´Ü °ñÀý(ÍéÓ®Íéï¹).
  • articular fracture =joint f.
    °üÀý °ñÀý, °üÀý³» °ñÀý(¡­Ò®Íéï¹).
  • atrophic fracture
    À§Ãà(¼º) °ñÀý(¡­Íéï¹).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fracture
    Àý´Ü
    [¿¾ ¿ë¾î] Àý´Ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fracture faces
    °ñÀý¸é(Íéï¹Øü)
  • fracture label
    °ñÀýÇ¥Áö(Íéï¹øöò½)
  • antigen-binding fragment
    Ç׿ø°áÇÕ(ù÷ê«Ì¿ùê) Á¶°¢
  • crystallizable fragment
    "°áÁ¤(Ì¿ïÜ) Á¶°¢, (ÔÒ) fc fragment"
  • Fab fragment
    Fab Á¶°¢
  • Fab' fragment
    Fab' Á¶°¢
  • F(ab')2 fragment
    F(ab')2 Á¶°¢
  • Fc fragment
    Fc Á¶°¢
  • Fd fragment
    Fd Á¶°¢
  • Fd' fragment
    Fd' Á¶°¢
  • (F1+F2) fragment
    (F1 + F2) Á¶°¢
  • F1 fragment
    F1 Á¶°¢
  • F2 fragment
    F2 Á¶°¢
  • F3 fragment
    F3 Á¶°¢
  • fragment ion
    Á¶°¢ ÀÌ¿Â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bone fragment
    °ñÆí
  • fragment
    ¼¼Æí, ÆÄÆí, ´ÜÆí, ºÐÀý, ÆíÀý, °ñÆí
  • gelfoam fragment
    Á©Æû Á¶°¢
  • apophyseal fracture
    °ñ´Ü°ñÀý
  • avulsion fracture
    °ß¿­°ñÀý
  • basal skull fracture
    µÎ°³ÀúºÎ°ñÀý
  • bending fracture
    ±¼°î°ñÀý
  • bent fracture
    ¿ä°î°ñÀý
  • bursting fracture
    ¹æÃ⼺°ñÀý
  • closed fracture
    Æó¼â¼º °ñÀý
  • comminuted fracture
    ºÐ¼â°ñÀý, ¼¼Æí°ñÀý
  • depressed fracture
    ÇÔ¸ô°ñÀý
  • fatigue fracture
    ÇǷΰñÀý
  • fracture
    °ñÀý, ÆÄ¼Õ
  • fracture dislocation
    °ñÀýÅ»±¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FS factor of safety; Fanconi syndrome; Felty syndrome; fibromyalgia syndrome; field stimulation; Fisher...
RFLPs Restriction Fragment Length Polymorphisms; Á¦ÇÑÈ¿¼Ò´ÜÆíÀå´ÙÇü
UGF Urinary Gonadotropin Fragment
B3F band 3 cytoplasmic fragment
EFC elastin fragment concentration; endogenous fecal calcium; ephemeral fever of cattle
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AFLP Amplified Fragment Length Polymorphism
CTF C-terminal fragment
FAFLP Fluorescent Amplified Fragment Length Polymorphism
HTF Hpa II tiny fragment
KF Klenow fragment
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fracture fragment
    °ñÀý Æí
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • transverse facial fracture : µ¿ÀǾî=Le Forte III fracture.

    transverse facial vein

    °¡·Î ¾ó±¼ µ¿¸Æ
  • amino fragment
    ¾Æ¹Ì³ë ÀýÆí
  • antigen binding fragment
    Ç׿ø °áÇÕ ºÎÀ§
  • bone fragment
    °ñÆí
  • carboxy fragment
    ź¼Ò ÀýÆí
  • detached fragment
    À¯¸®Æí, À¯¸® °ñÆí
  • enkephalin fragment
    ¿£ÄÉÆÈ¸° ºÐÀý
  • fragment
    ºÐÀý, ¼¼Æí, ÆÄÆí, ´ÜÆí, ÆíÀý, °ñÆí
    Å« Àüü°¡ ÆÄ±«µÇ¾î Çü¼ºµÈ ¼ÒÆí.
  • multiple biologically active peptide fragment
    ´Ù¹ß¼º »ý¹°ÇÐÀû Ȱ¼º ÆéŸÀÌµå ºÐÀý
  • prodynorphin-derived fragment
    ÇÁ·Î´ÙÀ̳븣ÇÉ À¯·¡ ºÐÀý
  • root fragment
    Ä¡±Ù ÆÄÆí, Ä¡±Ù ÀýÆí
  • angle fracture
    ¿ì°¢ºÎ °ñÀý
    Á¦ 2´ë±¸Ä¡ÀÇ ÈĹ濡¼­ ÇϾÇÁö¿Í ÇϾÇü¸¦ ¿¬°áÇÏ´Â ºÎºÐ±îÁö ¿¬°áµÈ °ñÀý.
  • articular fracture
    °üÀý °ñÀý, °üÀý³» °ñÀý
    µ¿ÀǾî=joint fracture.
  • basal skull fracture
    µÎ°³ÀúºÎ °ñÀý
  • bending fracture
    ±¼°î ÆÄÀý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acentric fragment A fragment of a chromosome lacking a centromere and unable to attach to the mitotic spindle, therefore unable to take part in the division of a nucleus and randomly distributed in daughter cells.
Synonym: acentric fragment.
(05 Mar 2000)
amplified fragment length polymorphism <technique> Invented by KeyGene, a Dutch biotech company based in Wageningen, Holland. The technique is now merchandised under licence agreement by Perkin Elmer.
Selected markers are amplified in a PCR, which makes amplified fragment length polymorphism an easy and fast tool for strain identification in agriculture, botany, microbiology and animal breeding.
Acronym: AFLP
(05 Feb 1998)
Brimacombe fragment A ribonucleoprotein fragment obtained by mild ribonuclease treatment of ribosomes.
(05 Mar 2000)
butterfly fragment A broad triangular fragment that is commonly present in comminuted fractures of the diaphysis.
(05 Mar 2000)
restriction fragment <molecular biology> The fragments of DNA generated by digesting DNA with a specific restriction endonuclease. Each of the fragments ends in a site recognised by that specific enzyme.
(10 Mar 1998)
restriction fragment length polymorphism <molecular biology, technique> A method that allows familial relationships to be established by comparing the characteristic polymorphic patterns that are obtained when certain regions of genomic DNA are amplified (typically by PCR) and cut with certain restriction enzymes.
The variation in the length of DNA fragments produced by a restriction endonuclease that cuts at a polymorphic locus. Such variations are generated by mutations that create or abolish recognition sites for these enzymes.
This is a key tool in DNA fingerprinting, reflecting the existence of different alleles in the individual. Restriction fragment length polymorphism mapping is also used in plant breeding to see if a key trait such as disease resistance is inherited.
In principle, an individual can be identified unambiquously by restriction fragment length polymorphism hence the use of restriction fragment length polymorphism in forensic analysis of blood, hair or semen).
Similarly, if a polymorphism can be identified close to the locus of a genetic defect, it provides a valuable marker for tracing the inheritance of the defect.
Synonym: DNA fingerprinting.
Acronym: RFLP
(12 Jan 1998)
Okazaki fragment A relatively short (100-1000 bp) fragment of DNA that is later joined by DNA ligase to allow for 3' &rarr; 5' overall chain growth during replication.
(05 Mar 2000)
one-carbon fragment The formyl group or the methyl group that takes part in transformylation or transmethylation reactions; by means of these reactions, a group containing a single carbon atom is added to a compound being biosynthesised, adding a methyl group (as in thymidine formation), adding a hydroxymethyl group (as in serine biosynthesis), or closing a ring (as in purine formation).
(05 Mar 2000)
two-carbon fragment The acetyl group (CH3CO-) that takes part in transacetylation reactions with coenzyme A as carrier; commonly referred to as acetate or acetic acid, from which it is derived.
(05 Mar 2000)
f2 fragment <immunology> A fragment of an antibody protein which includes the antigen-binding portions but not the Fc section. They can be produced by treating whole antibodies with proteases that will specifically cleave off the Fc section.
(09 Oct 1997)
Fab fragment The antigen-binding fragment of an immunoglobulin molecule, consisting of both a light chain and part of a heavy chain.
Synonym: Fab piece.
(05 Mar 2000)
Fc fragment <immunology> The constant region on an immunoglobulin molecule. The area that is exactly the same on all antibodies. The region is found on the heavy chains and is not involved in binding antigens.
(09 Oct 1997)
Klenow fragment <molecular biology> Larger part of the bacterial DNA polymerase I (76 kD) that remains after treatment with subtilisin, retains some but not all exonuclease and polymerase activity.
(18 Nov 1997)
fragment A small part broken from a larger entity.
(05 Mar 2000)
fragment reaction A reaction used to assay the activity of peptidyl transferase.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fission fragment
    Çٺп­ÀÇ ÆÄÆí
  • fragment
    ÆÄÆí;´ÜÆí;¹Ì¿Ï¼º À¯°í;ºÎ¼­Áø Á¶°¢;»ê»êÀÌ ºÎ¼ö´Ù;»ê»ê Á¶°¢ÀÌ µÇ´Ù;ºÎ¼­Áö´Ù
  • fracture
    °ñÀýÇÏ´Ù; ºÎ¼ö´Ù; °¥¶óÁø Æ´
  • compound fracture
    °³¹æ °ñÀý
  • fracture
    ºÎ¼û;°¥¶óÁø Æ´;±Ý;°ñÀý;ºÎ¼ö´Ù;ºÎ·¯¶ß¸®´Ù;°ñÀýÇÏ´Ù;ºÎ¼­Áö´Ù
  • greenstick fracture
    °ñÀýÀÇ ÀÏÁ¾(»ÀÀÇ ÇÑÂÊÀÌ ºÎ·¯Á® ´Ù¸¥ ÂÊÀ¸·Î ±¸ºÎ·¯Áü)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á